Clinical Trial Update: Immunotherapy of Natural Killer(NK) Cells in Human T Lymphotropic Virus Type 1(HTLV-1) Associated Myelopathy(HAM) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating immunotherapy using natural killer (NK) cells in patients with HTLV-1–associated myelopathy/tropical spastic paraparesis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1-associated Myelopathy Tropical Spastic Paraparesis

Drugs mentioned

• Natural killer cell immunotherapy (Natural killer cell immunotherapy)

Snippet

Sponsor: The Second Affiliated Hospital of Fujian Medical University | Conditions: HAM | Phase 1 | Status: UNKNOWN